Vasoactive drips are continuous intravenous infusions of medications that change blood pressure, heart function, or both. They’re used in intensive care settings when a patient’s cardiovascular system can’t maintain adequate blood flow on its own, most commonly during septic shock, heart failure, or after cardiac arrest. These medications fall into two broad categories: vasopressors, which tighten blood vessels to raise blood pressure, and inotropes, which strengthen the heart’s pumping ability.
How Vasopressors and Inotropes Differ
Blood pressure depends on two things: how much blood the heart pushes out with each beat (cardiac output) and how tightly the blood vessels squeeze around that blood (vascular resistance). Vasopressors primarily work by constricting blood vessels, increasing resistance and forcing blood pressure up. Inotropes take the other approach, making the heart muscle contract more forcefully so it pumps a greater volume of blood per beat.
Some medications do both. Several vasoactive drips cross the line between these categories depending on the dose, and a few are classified as “inodilators” because they strengthen the heart while simultaneously relaxing blood vessels. The choice of which drip to use depends on whether the problem is weak blood vessels, a weak heart, or some combination.
The Receptor System Behind These Drugs
Most vasoactive drips work by activating specific receptors on cells throughout the cardiovascular system. The three most important are alpha-1, beta-1, and beta-2 receptors. Alpha-1 receptors sit on blood vessel walls. When activated, they cause the vessel’s smooth muscle to contract, narrowing the vessel and raising blood pressure. Beta-1 receptors are concentrated in the heart. Stimulating them increases both heart rate and the force of each contraction. Beta-2 receptors are found in the lungs and blood vessels, where they cause relaxation and opening.
Each vasoactive medication has a different affinity for these receptors, which is what gives each drug its unique profile of effects. Some hit mainly alpha-1, some mainly beta-1, and some hit several receptor types at once.
Common Vasopressor Drips
Norepinephrine is the most widely used vasopressor in septic shock and is generally the first one started when a patient’s blood pressure drops dangerously low despite receiving IV fluids. It strongly activates alpha-1 receptors to constrict blood vessels while also providing some beta-1 stimulation to support the heart.
Vasopressin works through a completely different mechanism. Instead of targeting adrenergic receptors, it acts on its own receptor type (V1) on blood vessel walls to cause constriction. It has no direct effect on heart rate or contractility. In septic shock, it’s typically added alongside norepinephrine at a fixed rate of 0.03 units per minute rather than being continuously adjusted.
Phenylephrine is a pure alpha-1 agonist, meaning it constricts blood vessels without stimulating the heart at all. Because it raises blood pressure without increasing heart rate, the body’s reflexes can actually slow the heart down in response. This reflex slowing of heart rate is one reason it’s commonly used during spinal anesthesia for cesarean deliveries, where maintaining blood pressure without racing the heart is desirable.
Epinephrine activates alpha and beta receptors broadly, making it a powerful option when both blood pressure support and cardiac stimulation are needed. For low blood pressure and shock, it’s typically infused at 0.05 to 2 micrograms per kilogram per minute and adjusted every 10 to 15 minutes to reach the target blood pressure.
Dopamine’s Dose-Dependent Behavior
Dopamine is unusual among vasoactive drips because it activates entirely different receptors depending on how fast it’s infused. At low doses (0.5 to 2 micrograms per kilogram per minute), it stimulates dopamine-specific receptors and causes blood vessels in the kidneys and gut to relax. At moderate doses (5 to 10 micrograms per kilogram per minute), it shifts to primarily stimulating beta-1 receptors in the heart, increasing heart rate and contractility. Above 10 micrograms per kilogram per minute, alpha-1 effects dominate, constricting peripheral blood vessels and raising blood pressure, sometimes at the cost of reduced blood flow to the extremities.
This dose-dependent behavior means a single medication can be dialed to emphasize heart support or blood vessel constriction depending on what the patient needs.
Inotropic Drips for Heart Failure
When the primary problem is a heart that’s too weak to pump effectively, inotropes are the better choice. Dobutamine is a synthetic compound that activates beta-1 and beta-2 receptors, increasing the force of the heart’s contractions and improving cardiac output. It has relatively little effect on blood pressure directly, which makes it useful when the heart needs help but the blood vessels are functioning normally.
Milrinone takes a different path entirely. Rather than activating receptors on the outside of cells, it blocks an enzyme inside the cell (phosphodiesterase 3), which raises levels of a signaling molecule that strengthens heart contractions. At the same time, this mechanism causes blood vessels to relax and widen, which can actually lower blood pressure. Both dobutamine and milrinone are sometimes called “inodilators” because they combine heart-strengthening effects with blood vessel relaxation. A 2020 trial published in the New England Journal of Medicine compared the two directly in patients with cardiogenic shock and found them to be broadly similar in clinical effect.
How Vasoactive Drips Are Monitored
The primary target for titrating most vasoactive drips is mean arterial pressure, or MAP, a single number that represents the average pressure in the arteries during one complete heartbeat. For septic shock, the standard target is a MAP of at least 65 mmHg. In practice, ICU teams commonly aim for 65 to 70 mmHg, though targets can range from 55 to 90 mmHg depending on a patient’s age, chronic conditions, and whether there are signs that organs aren’t getting enough blood flow.
Patients on vasoactive drips have continuous blood pressure monitoring, often through an arterial line that gives a real-time reading with every heartbeat. The infusion rate is adjusted up or down in small increments to keep blood pressure within the target range. This process of gradual adjustment is called titration, and it requires close, often one-on-one nursing care.
Why Central Lines Are Preferred
Vasoactive drips are ideally given through a central venous catheter, a large IV placed in a major vein near the heart. The reason is safety: if a vasopressor leaks out of a regular peripheral IV into the surrounding tissue (a complication called extravasation), the same vessel-constricting effect that raises blood pressure can cut off blood flow to the skin and tissue around the IV site, potentially causing serious damage.
If extravasation does occur, the only FDA-approved treatment is injecting a counteracting medication (an alpha-blocker) directly into the affected area within 12 hours. Rapid infusion rates, high volumes, and prolonged use all increase the risk of extravasation with peripheral IVs, which is why central access is strongly preferred whenever vasoactive drips are expected to run for more than a short period.